US FDA accepts for review Berkshire Biomedical’s De Novo application for marketing authorization of COPA System: Dallas, Texas Tuesday, July 8, 2025, 15:00 Hrs [IST] Berkshire B ...

Classified as a tobacco product by the Food and Drug Administration (FDA), e-cigarettes are the most commonly used tobacco ...

Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal, paying $20 million for five new drug targets — and possibly spending more than a billion in milestone ...

Brain differences in children and teens who experiment with drugs early show up before they take their first puff or sip ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

Georgia's congressional delegation is advocating for FDA reconsideration of the drug elamipretide for Hope Filchak.

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...

A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to ...

Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by ...